{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:03:59Z","timestamp":1794953039491,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1038\/mtna.2016.7","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T12:27:50Z","timestamp":1458649670000},"page":"e297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Jana","family":"Miniarikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Huseinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Zon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Hanemaaijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raygene","family":"Martier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemart","family":"Koornneef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L","family":"Southwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander J","family":"van Deventer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Petry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Konstantinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2016.7_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1038\/mtna.2016.7_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1073858410386236","article-title":"Gene therapy in mouse models of huntington disease","volume":"17","author":"Southwell","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1038\/mtna.2016.7_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cge.12385","article-title":"Personalized gene silencing therapeutics for Huntington disease","volume":"86","author":"Kay","year":"2014","journal-title":"Clin Genet"},{"issue":"R1","key":"10.1038\/mtna.2016.7_bib4","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddr137","article-title":"RNAi medicine for the brain: progresses and challenges","volume":"20","author":"Boudreau","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.7_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/mds.26020","article-title":"Huntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing","volume":"29","author":"Aronin","year":"2014","journal-title":"Mov Disord"},{"key":"10.1038\/mtna.2016.7_bib6","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1093\/nar\/gkt725","article-title":"Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS","volume":"41","author":"\u00d8stergaard","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.7_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.7_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.expneurol.2011.11.020","article-title":"Widespread suppression of huntingtin with convection-enhanced delivery of siRNA","volume":"233","author":"Stiles","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1038\/mtna.2016.7_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/hum.2013.200","article-title":"Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Stanek","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2016.7_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1038\/mtna.2016.7_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1472-6750-12-42","article-title":"Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100","volume":"12","author":"Maczuga","year":"2012","journal-title":"BMC Biotechnol"},{"key":"10.1038\/mtna.2016.7_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.molmed.2012.09.001","article-title":"Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases","volume":"18","author":"Southwell","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1038\/mtna.2016.7_bib13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol Ther"},{"issue":"Pt 4","key":"10.1038\/mtna.2016.7_bib14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awr333","article-title":"Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum","volume":"135","author":"Grondin","year":"2012","journal-title":"Brain"},{"key":"10.1038\/mtna.2016.7_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","article-title":"Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"key":"10.1038\/mtna.2016.7_bib16","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.7_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"10.1038\/mtna.2016.7_bib18","doi-asserted-by":"crossref","first-page":"e99341","DOI":"10.1371\/journal.pone.0099341","article-title":"Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells","volume":"9","author":"Drouet","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.7_bib19","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1038\/mtna.2015.7","article-title":"Artificial miRNAs targeting mutant Huntingtin show preferential silencing in vitro and in vivo","volume":"4","author":"Monteys","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2016.7_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1038\/mtna.2016.7_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2016.7_bib22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/mt.2015.128","article-title":"Huntingtin haplotypes provide prioritized target panels for allele-specific silencing in Huntington disease patients of European Ancestry","volume":"23","author":"Kay","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.7_bib23","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats","volume":"39","author":"Fiszer","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.7_bib24","doi-asserted-by":"crossref","first-page":"e 24308","DOI":"10.1371\/journal.pone.0024308","article-title":"Targeting several CAG expansion diseases by a single antisense oligonucleotide","volume":"6","author":"Evers","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.7_bib25","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","author":"Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"10.1038\/mtna.2016.7_bib26","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.1371\/journal.pone.0002248","article-title":"Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi","volume":"3","author":"Ohnishi","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.7_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/exnr.2002.7942","article-title":"Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain","volume":"176","author":"Klein","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1038\/mtna.2016.7_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mtna.2016.7_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1042\/BST20140142","article-title":"Regulation of miRNA strand selection: follow the leader?","volume":"42","author":"Meijer","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1038\/mtna.2016.7_bib30","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1073\/pnas.1018023108","article-title":"Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes","volume":"108","author":"Gu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.7_bib31","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1093\/nar\/gkq575","article-title":"A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing","volume":"38","author":"Mart\u00ed","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.7_bib32","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1016\/j.febslet.2005.08.009","article-title":"Identification and characterization of small RNAs involved in RNA silencing","volume":"579","author":"Aravin","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1038\/mtna.2016.7_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"10.1038\/mtna.2016.7_bib34","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.7_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1038\/mtna.2016.7_bib36","first-page":"434","article-title":"In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs","volume":"7","author":"Borel","year":"2011","journal-title":"J RNAi Gene Silencing"},{"key":"10.1038\/mtna.2016.7_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1089\/hum.2011.035","article-title":"Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines","volume":"22","author":"Bish","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2016.7_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mtna.2016.7_bib39","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.7_bib40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.7_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem Biol"},{"key":"10.1038\/mtna.2016.7_bib42","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J"},{"key":"10.1038\/mtna.2016.7_bib43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.01.031","article-title":"Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing","volume":"152","author":"Auyeung","year":"2013","journal-title":"Cell"},{"key":"10.1038\/mtna.2016.7_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","article-title":"The Microprocessor complex mediates the genesis of microRNAs","volume":"432","author":"Gregory","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mtna.2016.7_bib45","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev"},{"key":"10.1038\/mtna.2016.7_bib46","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1261\/rna.032680.112","article-title":"In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs","volume":"18","author":"Gurtan","year":"2012","journal-title":"RNA"},{"key":"10.1038\/mtna.2016.7_bib47","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.1093\/nar\/gku979","article-title":"Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain","volume":"42","author":"Monteys","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.7_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mtna.2016.7_bib49","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1190809","article-title":"A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity","volume":"328","author":"Cifuentes","year":"2010","journal-title":"Science"},{"key":"10.1038\/mtna.2016.7_bib50","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1038\/mtna.2014.27","article-title":"Designing Ago2-specific siRNA\/shRNA to Avoid Competition with Endogenous miRNAs","volume":"3","author":"Ma","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2016.7_bib51","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1261\/rna.043950.113","article-title":"Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity","volume":"20","author":"Herrera-Carrillo","year":"2014","journal-title":"RNA"},{"key":"10.1038\/mtna.2016.7_bib52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.celrep.2013.09.029","article-title":"Poly(A)-specific ribonuclease mediates 3'-end trimming of Argonaute2-cleaved precursor microRNAs","volume":"5","author":"Yoda","year":"2013","journal-title":"Cell Rep"},{"key":"10.1038\/mtna.2016.7_bib53","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2014.08.005","article-title":"Emerging roles of RNA modification: m(6)A and U-tail","volume":"158","author":"Lee","year":"2014","journal-title":"Cell"},{"key":"10.1038\/mtna.2016.7_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm3611","article-title":"Diversifying microRNA sequence and function","volume":"14","author":"Ameres","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/mtna.2016.7_bib55","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/mtna.2016.7_bib56","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.celrep.2012.10.023","article-title":"Specific miRNA stabilization by Gld2-catalyzed monoadenylation","volume":"2","author":"D'ambrogio","year":"2012","journal-title":"Cell Rep"},{"key":"10.1038\/mtna.2016.7_bib57","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J Neurosci"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117300987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117300987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:23:18Z","timestamp":1761873798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253117300987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":57,"alternative-id":["S2162253117300987"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2016.7","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mtna.2016.7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Official journal of the American Society of Gene & Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e297"}}